STJ  St. Jude Medical Inc.




Health Care


Biotechnology: Electromedical & Electrotherapeutic Apparatus

Market Cap.


Vuru Grade


Current Price

+0.20 (+0.27%)

Growth Price

Overvalued by 25.75%

Stability Price

Overvalued by 71.80%

Company Metrics

  • 20.81 P/E
  • 3.66 P/S
  • 5.31 P/B
  • 3.51 EPS
  • 14.54% Cash ROIC
  • 0.54 Cash Ratio
  • 1.16 / 1.60 % Dividend
  • 1.53M Avg. Vol.
  • 20.54B Market Cap.

Company Description

St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. It operates in four segments: Cardiac Rhythm Management, Cardiovascular, Atrial Fibrillation, and Neuromodulation. The Cardiac Rhythm Management segment offers products for cardiac arrhythmias, or irregular heart beats. Its products include tachycardia implantab...

Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow


St. Jude Medical Announces Launch of the First International Trial to Compare ...
Business Wire (press release) - 4 hours ago
ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced the launch of the ILUMIEN III clinical trial, a prospective, international, randomized trial evaluating the clinical benefits of the ...
Notable Session Mover: St. Jude Medical, Inc. (NYSE:STJ)
Vanguard Tribune - 39 minutes ago
A notable mover in today's trading session is St. Jude Medical, Inc. (NYSE:STJ) as the stock opened the most recent session at 73.62 and at the time of writing the last Bid was at 73.12.
St Jude Medical (STJ) Hits New Lifetime High - Jun 22, 2015
St. Jude Medical, Inc., together with its subsidiaries, develops, manufactures and distributes cardiovascular medical devices for cardiac rhythm management, cardiovascular, and atrial fibrillation therapy areas worldwide.
Company Shares of St. Jude Medical, Inc. Rally 1.78% - American Trade Journal
St. Jude Medical, Inc. to Issue Quarterly Dividend of $0.29 on July 31st (STJ) - Mideast Time
St. Jude Medical's Axium System Found to Provide Superior Pain Relief Over ...
Business Wire (press release) - Jun 8, 2015
ST. PAUL, Minn. & MONTREAL--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced data from the ACCURATE Study shows that stimulation of the dorsal root ganglion (DRG) with the St. Jude Medical ...
St. Jude Medical announces data from ACCURATE Study - Quick facts - RTT News
Is St. Jude Medical Inc. Underpriced? (NYSE:STJ)
Stock Markets Daily - Jun 11, 2015
We look at St. Jude Medical Inc. (NYSE:STJ) a company in the Healthcare industry which lately stock market players have been interested in, to assess if it provides value for investors considering buying or selling it.
Brokerage Firm Ratings Update on St. Jude Medical, Inc. (NYSE:STJ) - Investor Newswire
Morningstar Assigns "AA-" Credit Rating to St. Jude Medical (STJ) - Dakota Financial News
St. Jude Medical Hits 52-Week High on Pipeline Strength - Jun 12, 2015
Earlier this month, St. Jude Medical's Invisible Trial System - an app-based neuromodulation programming system - was CE marked and launched in Europe.
St. Jude Medical, Inc. Analyst Rating Update - Insider Trading Report
FDA approves St. Jude's brain implant for Parkinson's disease
Reuters - Jun 12, 2015
The U.S. Food and Drug Administration said it approved a brain implant from St. Jude Medical Inc that helps reduce symptoms of Parkinson's disease and essential tremor, a neurological disorder that causes rhythmic shaking.
FDA clears St. Jude Medical's neurostimulator - Seeking Alpha
FDA approves brain implant to help reduce Parkinson's disease and essential ... -
Company Shares of St. Jude Medical, Inc. Drops by -1.69%
American Trade Journal - Jun 29, 2015
St. Jude Medical, Inc. (NYSE:STJ) has dropped 1.69% during the past week, however, the bigger picture is still very bullish; the shares have posted positive gains of 0.85% in the last 4 weeks.
Shares of St. Jude Medical, Inc. (NYSE:STJ) Sees Large Outflow of Money - OTC Outlook
St. Jude Medicals (STJ) Invisible Trial System CE Marked - Jun 5, 2015
St. Jude Medical Inc. (STJ - Analyst Report) recently announced CE Mark approval and the European launch of its Invisible Trial System - an app-based neuromodulation programming system which employs Apple Inc.'s (AAPL - Analyst Report) and Bluetooth ...
St. Jude Medical Receives CE Mark Approval of Industry's First Neuromodulation ... - Yahoo Finance UK
New St. Jude device treats chronic pain using an iPod - Minneapolis Star Tribune
St. Jude Medical Announces Second Quarter 2015 Earnings Conference Call
MarketWatch - Jun 25, 2015
St. Jude Medical is a global medical device manufacturer dedicated to transforming the treatment of some of the world's most expensive epidemic diseases.
St. Jude Medical, Inc. (STJ) Ex-Dividend Date Scheduled for June 26, 2015 - Nasdaq